PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Salmeterol
Presentation Product Chemical substance Chapter Items dispensed
Salmeterol 25micrograms/dose inhaler CFC free
0301011U0AAAHAH
Salmeterol Salmeterol Respiratory System 28,265
Serevent 25micrograms/dose Evohaler
0301011U0BBAFAH
Serevent Salmeterol Respiratory System 13,522
Serevent 50micrograms/dose Accuhaler
0301011U0BBAEAE
Serevent Salmeterol Respiratory System 5,205
Salmeterol 50micrograms/dose dry powder inhaler
0301011U0AAAEAE
Salmeterol Salmeterol Respiratory System 5,168
Soltel 25micrograms/dose inhaler CFC free
0301011U0BGAAAH
Soltel Salmeterol Respiratory System 3,002
Neovent 25micrograms/dose inhaler CFC free (Kent Pharm)
0301011U0BEAAAH
Neovent (Fannin) Salmeterol Respiratory System 120
Serevent 25micrograms/dose inhaler
0301011U0BBACAC
Serevent Salmeterol Respiratory System 11
Salmeterol 25micrograms/dose inhaler
0301011U0AAACAC
Salmeterol Salmeterol Respiratory System 1
Neovent 25micrograms/dose inhaler CFC free (Teva)
0301011U0BDAAAH
Neovent (Teva) Salmeterol Respiratory System No data available
Salmeterol 50microgram inhalation pdr blist with device
0301011U0AAAAAA
Salmeterol Salmeterol Respiratory System No data available
Salmeterol 50microgram inhalation powder blisters
0301011U0AAABAB
Salmeterol Salmeterol Respiratory System No data available
Serevent 50microgram disks
0301011U0BBABAB
Serevent Salmeterol Respiratory System No data available
Serevent 50microgram disks with Diskhaler
0301011U0BBAAAA
Serevent Salmeterol Respiratory System No data available
Vertine 25micrograms/dose inhaler CFC free
0301011U0BFAAAH
Vertine Salmeterol Respiratory System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.